(Bloomberg) -- The effort to convert Pfizer Inc.’s former New York headquarters into residences secured financing to help ...

The transformation of a pharmaceutical giant's former headquarters is setting records in New York City's real estate market, with developers securing an enormous loan to make it happen. NYC leads ...

WASHINGTON — The release of COVID-19 vaccine results after the 2020 election may have not been a “coincidence” — and could have been part of an effort by senior Pfizer executives to ...

Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company's sales fell, largely due to dwindling revenue for its antiviral ...

Pfizer signage is displayed at the Pfizer NYC Headquarters, Thursday, April 10, 2025, in New York. (AP Photo/Yuki Iwamura) (Yuki Iwamura, Copyright 2025 The ...

Pfizer Inc. plans to spend billions of dollars to join the race for a new type of cancer treatment. Similar to its competitors, Pfizer also plans to partner with a Chinese company. The company PFE ...

Shares in 5,432 companies trade every day starting at 9:30 on the New York Stock Exchange or Nasdaq. They had an interesting ride Monday. In the first 15 minutes of trading all but 70 of all ...

Pfizer PFE1.02%increase; green up pointing triangle had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient in a trial suffered a liver injury potentially caused by the drug.

Pfizer signage is displayed at the Pfizer NYC Headquarters, Thursday, April 10, 2025, in New York. (AP Photo/Yuki Iwamura) 31,039 people played the daily Crossword recently. Can you solve it ...